Alex Gorsky and Sheri McCoy Named Vice Chairs of Johnson & Johnson Executive Committee


Johnson & Johnson promoted the heads of its medical device unit and its pharmaceuticals division to vice chairmen on Wednesday, a move that could put them in competition to succeed Chief Executive and Chairman William Weldon.
The diversified healthcare company, which has been strapped with repeated recalls of its consumer products in the past year, said Alex Gorsky - its global chairman of medical devices and diagnostics - and Sheri McCoy - global chair of pharmaceuticals - become vice chairs of the executive committee and join Weldon in an expanded office of the chairman. The moves are effective Jan. 3. Wall Street has been expecting Weldon to retire in the next year or so, although some analysts have predicted he could remain a bit longer in an attempt to put the company's troubled consumer products division back into order.
most read

Valerie Diele-Braun Leaves IMCD
Valerie Diele-Braun resigned from her position as CEO and member of the Executive Board of IMCD at the end of April for personal reasons.

Supply Chain and Logistics Trends in the Chemical Industry
This interview covers key results of the study ‘Success Factor Supply Chain Management and Logistics in the Chemical Industry 2024’ by Solventure, Aimms and Miebach.

Orion Announced Plans to Shut Down Carbon Black Plants
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.

Honeywell to Acquire Johnson Matthey's Catalyst Technologies Business
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.

Dow to Shut Down Three Upstream European Assets
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.